Top

Published in:

01-06-2010 | Research Article

Modifications in tissue kallikrein activity with indomethacin and prednisolone treatment in arthritic rats

Author: J. N. Sharma

Published in: Inflammopharmacology | Issue 3/2010

Abstract

This investigation was conducted to evaluate the tissue kallikrein activity in the synovial and paw tissues of control, non-treated adjuvant arthritic and adjuvant arthritic rats treated either with indomethacin or prednisolone. Adjuvant arthritis was induced in male Sprague–Dawley rats in the right knee by injecting 0.05 ml of a fine suspension of heat-killed Mycobacterium tubercle bacilli in liquid paraffin (5 mg/ml). Indomethacin (2.5 mg/kg given orally) and prednisolone (3.0 mg/kg given orally) treatment for 9 days caused a significant reduction (P < 0.001) in knee swelling. In non-treated adjuvant rats, synovial tissue kallikrein levels were raised (P < 0.01) than the synovial tissue kallikrein obtained from control normal rats. Prednisolone treatment resulted in reduction (P < 0.05) and indomethacin treatment produced raise (P < 0.01) in synovial tissue kallikrein levels. In non-treated arthritic rats, the paw tissue kallikrein levels were lower (P < 0.001) than the control rats; whereas, rats treated with prednisolone and indomethacine showed higher levels (P < 0.05) of paw tissue kallikrein. These results may suggest that the prednisone and indomethacin differ in their actions in inflamed synovial tissue kallikrein and have a similar effect in non-inflamed paw tissues.

Al-Haboubi HA, Bennett D, Sharma JN et al (1986) A synovial amidase acting on tissue kallikrein-selective substrate in clinical and experimental arthritis. Adv Exp Med Biol B 198:404–411

Amundsen E, Putter J, Friberger P et al (1979) Method for determination of glandular kallikrein by means of chromogenic tripeptide substrate. Adv Exp Med Biol A 120:83–95

Edery H, Lewis GP (1963) Kinin-forming activity and histamine in lymph after tissue injury. J Physiol 169:568–573PubMed

Farmer SG, Burch RM, meeker SA et al (1989) Evidence for a pulmonary B3 bradykinin receptor. Mol Pharmacol 36:1–8PubMed

Newbould BB (1963) Chemotherapy of arthritis induced in rats by injection of Mycobacterial adjuvant. Br J Pharmacol 21:127–136

Regoli D, Barabe J (1980) Pharmacology of bradykinin and related kinins. Pharmacol Rev 32:1–46PubMed

Sharma JN (1991) The role of kinin system in joint inflammatory disease. Eur J Rheumatol Inflamm 11:30–37PubMed

Sharma JN (1993) Therapeutic prospects of bradykinin receptor antagonists. Gen Pharmacol 24:267–274PubMed

Sharma JN (2005) The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection. Inflammopharmacology 12:591–596CrossRefPubMed

Sharma JN, Buchanan WW (1994) Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease. Exp Toxicol Pathol 46:421–433PubMed

Sharma JN, Sharma JN (1977) Comparison of anti-inflammatory activity of Commiphora mukul (an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by Mycobacterial adjuvant. Arzneim-Forsh 27:1455–1457

Sharma JN, Wirth KJ (1996) Inhibition of rats adjuvant arthritis by a bradykinin antagonist Hoe 140 and its influence on kallikrein. Gen Pharmacol 27:133–136CrossRefPubMed

Sharma JN, Zeitlin IJ, Deodhar SD et al (1983) Detection of kallikrein-like activity in the inflamed synovial tissue. Arch Int Pharmacodyn Ther 262:279–286PubMed

Sharma JN, Zubaid M, Khan BZSJ et al (2000) Pathophysiological activities of the kallikrein-kinin system with emphasis on the cardiovascular disorders. Inflammopharmacology 8:219–241CrossRef

Star MS, West GB (1967) Bradykinin and oedema formation in heated paw of rats. Br J Pharmacol 31:178–184

Van Arman CG, Nuss GW (1969) Plasma bradykininogen levels in adjuvant arthritis and carrageenan inflammation. J Pathol 99:245–250CrossRefPubMed

Waller DG, Bhatia SS, Campbell SK et al (1990) active and inactive urinary kallikrein in man: effect of dieresis and antidiuresis. Clin Sci 79:117–121PubMed

Yamaguchi Y, Tanaka Y, Yamada K et al (1989) Abnormal lipid metabolism in adjuvant arthritic rats. Jpn J Pharmacol 50:377–386CrossRefPubMed

Zach HP, Werle E (1972) Changes in kininogen content of serum and some organs during injury and inflammation in rats. Adv Exp Med Biol 21:371–379

Zach HP, Werle E (1973) Uber den kininnogen-gehalt von serum und plasma nach gewebsschadigung bei ratten. Arch Pharmacol 276:167–173CrossRef

Title: Modifications in tissue kallikrein activity with indomethacin and prednisolone treatment in arthritic rats
Author: J. N. Sharma
Publication date: 01-06-2010
Publisher: SP Birkhäuser Verlag Basel
Published in: Inflammopharmacology / Issue 3/2010
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-010-0034-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Modifications in tissue kallikrein activity with indomethacin and prednisolone treatment in arthritic rats

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2010

Constitutive nitric oxide synthase-mediated caspase-3 S-nitrosylation in ghrelin protection against Porphyromonas gingivalis-induced salivary gland acinar cell apoptosis

Effect of hexane fraction of leaves of Cinnamomum tamala Linn on macrophage functions

Evaluation of antiulcer and antisecretory potential of Linum usitatissimum fixed oil and possible mechanism of action

Therapeutic effect of Linum usitatissimum (flaxseed/linseed) fixed oil on acute and chronic arthritic models in albino rats

Electronic data capture using the Womac® NRS 3.1 Index (m-Womac®): a pilot study of repeated independent remote data capture in OA